- Home
- MYFW vs INBX Comparison
MYFW vs INBX Comparison
Compare MYFW & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MYFW | INBX |
|---|---|---|
| Founded | 2002 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 220.8M | 430.2M |
| IPO Year | 2018 | 2020 |
Fundamental Metrics
Financial Performance| Metric | MYFW | INBX |
|---|---|---|
| Price | $25.67 | $75.22 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 2 |
| Target Price | ★ $24.25 | N/A |
| AVG Volume (30 Days) | 27.3K | ★ 236.0K |
| Earning Date | 01-22-2026 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 391.62 | N/A |
| EPS | ★ 1.28 | N/A |
| Revenue | ★ $95,514,000.00 | $1,400,000.00 |
| Revenue This Year | $15.96 | $563.00 |
| Revenue Next Year | $13.77 | $230.77 |
| P/E Ratio | $20.07 | ★ N/A |
| Revenue Growth | ★ 19.92 | N/A |
| 52 Week Low | $17.10 | $10.81 |
| 52 Week High | $26.28 | $94.47 |
Technical Indicators
Market Signals| Indicator | MYFW | INBX |
|---|---|---|
| Relative Strength Index (RSI) | 70.73 | 46.07 |
| Support Level | $23.72 | $79.00 |
| Resistance Level | $26.28 | $94.47 |
| Average True Range (ATR) | 0.57 | 5.90 |
| MACD | 0.18 | -2.08 |
| Stochastic Oscillator | 76.70 | 5.29 |
Price Performance
Historical ComparisonAbout MYFW First Western Financial Inc.
First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.